Literature DB >> 24891548

Time to screening in the systems of support to increase colorectal cancer screening trial.

Ching-Yun Wang1, Jean de Dieu Tapsoba2, Melissa L Anderson3, Sally W Vernon4, Jessica Chubak5, Sharon Fuller3, Beverly B Green6.   

Abstract

Understanding how interventions affect time to completion of colorectal cancer screening might assist in planning and delivering population-based screening interventions. The Systems of Support to Increase Colorectal Cancer Screening (SOS) study was conducted between 2008 and 2011 at 21 primary care medical centers in Western Washington. Participants in the study, ages 50 to 73 years, were eligible if they were enrolled in Group Health (Seattle, WA) and were due for colorectal cancer screening. Of note, 4,675 recruited participants were randomized to usual care or one of three interventions with incremental levels of systems of support for completion of colorectal cancer screening. We conducted time to screening analyses of the SOS data in years 1 and 2. We investigated whether these effects were time-varying. For year 1, the intervention effects on the time to completion of colorectal cancer screening were the strongest during the first two post-randomization months and then decreased, with no significant effect after the fifth month. For year 2, the intervention effects on the time to colorectal cancer screening increased from the first to the third month and then decreased, with no significant effect after the fifth month. Hence, each of the interventions to increase colorectal cancer screening had its greatest effect within the first 3 months after being offered to participants. Future studies should test whether booster interventions offered later could increase screening rate among those who remain unscreened. Additional research is needed to develop intervention strategies for colorectal cancer screening that focus on sustained behavior over time. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 24891548      PMCID: PMC4119537          DOI: 10.1158/1055-9965.EPI-14-0270

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  10 in total

1.  Proportional hazards model with random effects.

Authors:  F Vaida; R Xu
Journal:  Stat Med       Date:  2000-12-30       Impact factor: 2.373

2.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

Review 3.  Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Authors:  P Hewitson; P Glasziou; L Irwig; B Towler; E Watson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

4.  Systems of support to increase colorectal cancer screening and follow-up rates (SOS): design, challenges, and baseline characteristics of trial participants.

Authors:  Beverly B Green; C Y Wang; Kathryn Horner; Sheryl Catz; Richard T Meenan; Sally W Vernon; David Carrell; Jessica Chubak; Cynthia Ko; Sharon Laing; Andy Bogart
Journal:  Contemp Clin Trials       Date:  2010-07-30       Impact factor: 2.226

5.  Effectiveness and reach of the FLU-FIT program in an integrated health care system: a multisite randomized trial.

Authors:  Michael B Potter; Lynn M Ackerson; Vicky Gomez; Judith M E Walsh; Lawrence W Green; Theodore R Levin; Carol P Somkin
Journal:  Am J Public Health       Date:  2013-04-18       Impact factor: 9.308

6.  Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.

Authors:  Brenda K Edwards; Elizabeth Ward; Betsy A Kohler; Christie Eheman; Ann G Zauber; Robert N Anderson; Ahmedin Jemal; Maria J Schymura; Iris Lansdorp-Vogelaar; Laura C Seeff; Marjolein van Ballegooijen; S Luuk Goede; Lynn A G Ries
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

7.  Contribution of screening and survival differences to racial disparities in colorectal cancer rates.

Authors:  Iris Lansdorp-Vogelaar; Karen M Kuntz; Amy B Knudsen; Marjolein van Ballegooijen; Ann G Zauber; Ahmedin Jemal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-04-18       Impact factor: 4.254

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

9.  An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial.

Authors:  Beverly B Green; Ching-Yun Wang; Melissa L Anderson; Jessica Chubak; Richard T Meenan; Sally W Vernon; Sharon Fuller
Journal:  Ann Intern Med       Date:  2013-03-05       Impact factor: 25.391

10.  Vital signs: colorectal cancer screening test use--United States, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-11-08       Impact factor: 17.586

  10 in total
  2 in total

1.  Can we achieve an 80% screening rate for colorectal cancer by 2018 in the United States?

Authors:  Electra D Paskett; Fadlo R Khuri
Journal:  Cancer       Date:  2015-03-12       Impact factor: 6.860

2.  Analytic Challenges Arising from the STOP CRC Trial: Pragmatic Solutions for Pragmatic Problems.

Authors:  William M Vollmer; Beverly B Green; Gloria D Coronado
Journal:  EGEMS (Wash DC)       Date:  2015-12-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.